Tue.Jul 30, 2024

article thumbnail

Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive

Fierce Pharma

For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. | For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. And while the busy has been busy trimming operating expenses, it did add $1 billion to its total revenue projection for the year.

Sales 299
article thumbnail

Analysis: Humana is Boldly Going Where Walmart Stumbled

MedCity News

Humana is leasing clinical space at 23 Walmart Supercenter retail stores. The move is logical for the insurer as it builds out its senior primary care business, experts say. The post Analysis: Humana is Boldly Going Where Walmart Stumbled appeared first on MedCity News.

Retail 134
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sanofi sues Sarepta, claiming Duchenne gene therapy Elevidys infringes 2 manufacturing patents

Fierce Pharma

Six months after surviving a patent challenge involving its $3.2 million gene therapy, Sarepta faces a new lawsuit from another gene therapy developer claiming the approved treatment infringes its | Six months after surviving a patent challenge involving its $3.2 million gene therapy, Sarepta faces a new lawsuit from another gene therapy developer claiming the approved treatment infringes active patents.

article thumbnail

Eco HPLC-based method shows promise for Z-alkene synthesis

European Pharmaceutical Review

Japanese researchers have developed a new method for photoisomerisation of E -cinnamamides to Z -cinnamamides. The approach uses a recycling photoreactor coupled with a high-performance liquid chromatography (HPLC) system. As organic compounds, many Z -alkenes “cannot be prepared through conventional methods involving thermodynamic methods”. On the other hand, “photoisomerisation can offer good yields”, they noted.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Incyte touts 2 trial wins for PD-1 drug Zynyz, eyes comeback in anal cancer

Fierce Pharma

Incyte is gunning for a first-in-class nod for PD-1 inhibitor Zynyz in anal cancer again after being turned away by the FDA in 2021. | Incyte is gunning for a first-in-class nod for its PD-1 inhibitor Zynyz in anal cancer again after being turned away by the FDA in 2021. But regulatory uncertainties remain.

FDA 173
article thumbnail

Spinal Surgery in The Setting of Complex Medical Conditions

MedCity News

Empathy gets rationed when a high-volume practice is valued over a high-quality practice by administrators who aren’t seeing the patients in clinic — but patients rely on surgeons who can embrace the complex conditions. The post Spinal Surgery in The Setting of Complex Medical Conditions appeared first on MedCity News.

Medical 111

More Trending

article thumbnail

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Aneesh Chopra, Chief Strategy Officer at Arcadia

MedCity News

In this month’s episode, Senior Reporter Katie Adams discussed some executive moves and layoffs that recently occurred in the healthcare sector. She also interviewed Aneesh Chopra, who transitioned to the role chief strategy officer at Arcadia following the company’s recent merger with his startup, CareJourney. The post MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Aneesh Chopra, Chief Strategy Officer at Arcadia appeared first on MedCity News.

article thumbnail

Approaching the regulatory world with passion: CERs and EU MDR processes

pharmaphorum

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ethan Drower, co-founder and CEO of Cite Medical Solutions, a company providing full Clinical Evaluation Report (CER) services and industry literature review for European Union Medical Device Regulation (or EU MDR) processes.

Medical 110
article thumbnail

Why One Physical Therapy Provider Thinks Hybrid Care is Key

MedCity News

Band Connect’s founders believe their startup’s unique hybrid physical therapy model is helpful in boosting both compliance and outcomes. The post Why One Physical Therapy Provider Thinks Hybrid Care is Key appeared first on MedCity News.

111
111
article thumbnail

Pharma Pulse 7/30/24: The Doctor Will See You Now, But AI May Be Listening In.The Importance of Genomic Sequencing in the Battle Against HIV in South Africa & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Thwarting The Next Surge: A Tactical Plan to Improve Covid-19 Vaccination Uptake

MedCity News

In the face of new variants and lower public acceptance of vaccination, it’s imperative that we take stock of lessons learned from previous seasons and examine key barriers to uptake as we prepare for this fall and winter – from adjusting approval timelines at the federal level, to implementing programs to address vaccine complacency, convenience and confidence.

article thumbnail

Older GLP-1 drug shows glimmer of benefit in Alzheimer's

pharmaphorum

A small study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide shows a benefit in patients with Alzheimer's disease

Patients 105
article thumbnail

With FDA Nod for Colorectal Cancer Screening, How Much Market Share Can Guardant’s Blood Test Get?

MedCity News

Guardant Health’s Shield, a liquid biopsy that screens for colorectal cancer by analyzing a patient blood sample, will compete against stool-based tests already established in the market. Shield could also face new competition from other liquid biopsy companies. The post With FDA Nod for Colorectal Cancer Screening, How Much Market Share Can Guardant’s Blood Test Get?

Marketing 105
article thumbnail

BioNTech cancer vaccine hits the spot in melanoma

pharmaphorum

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma.The study is looking at the combination of BNT111 with Regeneron's PD-1 inhibitor Libtayo (cemiplimab) in 184 patients with advanced melanoma who have relapsed after or not responded to treatment with a PD-1/PD-L1 inhibitor, or the two therapies given alone.

Patients 102
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

The Science of Stories: Leveraging Storytelling to Enhance Sales

Quantified

The Power of Storytelling in Sales When was the last time you got lost in a story? Whether in a book, podcast, or movie, a well-told story has a powerful impact on its audience. When messages delivered as stories can be up to 22 times more memorable than mere facts. Stories engage multiple parts of our brains, enhancing focus and retention. Your Brain on Stories Neurological Engagement: Stories activate multiple brain areas, including motor cortexes, emotion, and visual processing centers, makin

Sales 98
article thumbnail

Boehringer buys oncology player Nerio in $1.3bn deal

pharmaphorum

Boehringer buys Nerio Therapeutics for $1.

101
101
article thumbnail

Study finds semaglutide decreases tobacco-related healthcare

Pharmaceutical Technology

Semaglutide, marketed as Ozempic and Wegovy, decreased tobacco-related healthcare encounters compared to other medications.

article thumbnail

HDR UK and DPUK granted £2m for new motor neurone disease research initiative

PharmaTimes

The rapidly progressive neurological condition affects around 5,000 people in the UK

88
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

GSK and Flagship Pioneering link for new medicines and vaccines

Pharmaceutical Technology

GSK has announced a strategic collaboration with Flagship Pioneering for the discovery and development of medicines and vaccines.

article thumbnail

Cognition's SHINE data for Alzheimer's drug dulls prospects

pharmaphorum

Cognition Therapeutics has reported phase 2 data with its Alzheimer's disease candidate, claiming the results show proof-of-concept for the drug, although the study missed its main endpoint.Cognition's stock lost more than 40% of its value in trading after the data was presented yesterday, and slipped another 20% after hours, despite assertions by the New York biotech that its CT182 drug showed "consistent" improvements in cognitive outcomes compared to placebo in the SHINE study.

article thumbnail

Study reveals new insights into ‘gene misbehaviour’ in healthy populations

PharmaTimes

The findings could support investigations into human genetics and various complex diseases

74
article thumbnail

Doing More with Less in Sales

Quantified

Leveraging AI for Success Executive Summary: Explore how integrating AI can help sales teams maximize productivity and efficiency. AI tools streamline processes, prioritize leads, and enhance performance. With capabilities like data integration, real-time analytics, and personalized coaching, AI enables sales teams to work smarter, not harder, even with limited resources.

Sales 65
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Collegium buys Ironshore for $525m and enter ADHD market

Pharmaceutical Technology

Collegium will pay $525m upfront to add Ironshore’s FDA-approved ADHD medication Jornay PM to its portfolio.

article thumbnail

Cinnamon May Reduce Risk of Cardiovascular Disease in Patients with PCOS

Pharmacy Times

Polycystic ovary syndrome (PCOS) is closely associated with an increased risk of cardiovascular disease.

article thumbnail

Ventyx scraps TYK2 inhibitor after Phase II Crohn’s defeat 

Pharmaceutical Technology

Ventyx no longer plans to conduct additional clinical trials of VTX958 with internal resources after the Phase II trial missed its primary endpoint.

52
article thumbnail

FDA Extends Palforzia Approval to Children 1 to 3 Years Old With Peanut Allergy

Pharmacy Times

The approval marks the first oral immunotherapy treatment to mitigate allergic reactions, including anaphylaxis.

FDA 55
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

FDA Approves Luye Pharma Group’s Erzofri for Adults with Schizophrenia, Schizoaffective Disorder

PharmExec

Erzofri is the first patented paliperidone palmitate long-acting injectable developed in China to receive FDA approval for treating schizophrenia and schizoaffective disorder, company says.

FDA 52
article thumbnail

Avutometinib With Defactinib Granted FDA Orphan Drug Designation to Treat Pancreatic Cancer

Pharmacy Times

The designation is based off positive results from the RAMP 205 trial presented at the ASCO Annual Meeting.

FDA 55
article thumbnail

10 Ways to Improve Video Calls with Prospects

Quantified

Selling in a virtual world is challenging. For reps who thrive in person, gone are the days of meeting prospects at conferences, dinners, and golf outings. Now, high-value solutions are sold over video calls. Even for reps accustomed to virtual sales, the very real phenomenon of Zoom fatigue means the competition for the buyer’s attention is higher than ever as tech-tired prospects juggle browser tabs, Slack notifications, and their newly merged home and work lives.

article thumbnail

Community Pharmacy Managers, Owners Must Address Workplace Violence

Pharmacy Times

Although important for patient health care, pharmacies’ convenient locations leave staff prone to workplace violence.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A